Gallium-68 HA-DOTATATE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gallium-68 HA-DOTATATE, covering 2023-10-18 to 2023-10-18. Get the full timeline:
Most recent: Clinical Trial Update: Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA) [Phase 2]